C -Substituted Imino-D-xylitols (DIXs) by Click Chemistry (original ) (raw )Glucocerebrosidase Enhancers for Selected Gaucher Disease Genotypes by Modification of α-1- C -Substituted Imino- D -xylitols (DIXs) by Click Chemistry
Antonio Afonso Delgado
ChemMedChem, 2014
View PDFchevron_right
Bicyclic Derivatives of L -Idonojirimycin as Pharmacological Chaperones for Neuronopathic Forms of Gaucher Disease
Pilar Alfonso
ChemBioChem, 2013
View PDFchevron_right
Second-Generation Iminoxylitol-Based Pharmacological Chaperones for the Treatment of Gaucher Disease
Éric Lesellier
ChemMedChem, 2011
View PDFchevron_right
Identification of Modulators of the N370S Mutant Form of Glucocerebrosidase as a Potential Therapy for Gaucher Disease-Chemotype 2
Noel Southall
View PDFchevron_right
Use of the L-idonojirimycin derivatives as pharmacological chaperones for the treatment of Gaucher disease
Pilar Alfonso
Molecular Genetics and Metabolism, 2013
View PDFchevron_right
A Fluorescent sp2-Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution Studies
Eiji Nanba
ChemBioChem, 2010
View PDFchevron_right
High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase
Noel Southall
PLoS ONE, 2012
View PDFchevron_right
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
Allan Powe
Febs Journal, 2010
View PDFchevron_right
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
pedro huertas
Nature Chemical Biology, 2006
View PDFchevron_right
Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase
Adrian Velazquez-Campoy , Pilar Giraldo
Molecular pharmaceutics, 2011
View PDFchevron_right
Probing the Inhibitor versus Chaperone Properties of sp2-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease
Roland Pieters
Molecules, 2018
View PDFchevron_right
Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy
Alla Shainskaya
Biological Chemistry, 2008
View PDFchevron_right
Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders
Raymond Dwek
Philosophical Transactions of the Royal Society B: Biological Sciences, 2003
View PDFchevron_right
Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease
Gessami Sanchez-Olle , Daniel Grinberg
The International Journal of Biochemistry & Cell Biology, 2014
View PDFchevron_right
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease
Mario Cordero
Scientific reports, 2015
View PDFchevron_right
α-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease
Liang Yu , Philippe Compain , Guillaume Godin
Bioorganic & Medicinal Chemistry, 2006
View PDFchevron_right
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
J. Inglese , Douglas Auld
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Deepangi Pandit
Journal of Biological Chemistry, 2009
View PDFchevron_right
Transgenic mice expressing human glucocerebrosidase variants: Utility for the study of Gaucher disease
Leanne Hein
Blood Cells, Molecules, and Diseases, 2013
View PDFchevron_right
A new glucocerebrosidase deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
Carole Cramer
Disease Models & Mechanisms, 2016
View PDFchevron_right
Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease
Gary Murray
Journal of Inherited Metabolic Disease, 1994
View PDFchevron_right
Gaucher's disease: the changing paradigm of a lysosomal disorder
Atul Mehta
Medicina Clínica, 2011
View PDFchevron_right
Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds
Montserrat Barragan
Human Molecular Genetics, 2013
View PDFchevron_right